HOPE Hydration and Times Square Alliance Unveil Interactive Hydration Experience for Times Square Visitors
New York, New York--(Newsfile Corp. - August 2, 2023) - HOPE Hydration, the startup known for its smart-city water stations,...
Year: 2023
Cognetivity Neurosciences Announces Successful Registration With Health Canada for Clinical use of CognICA(TM) AI-Powered Brain Health Technology in Canada
Approval opens up a new major market for CognICA, providing a solution to the urgent requirement for large-scale early detection...
Cedar Builds AI-Powered Tools to Improve Healthcare Financial Experience for Patients Across the United States in Collaboration With Google Cloud
Collaboration Will Accelerate Development of Large Language Models Within the Cedar Suite to Increase Transparency and Access Within Healthcare Billing...
Unify Medical Announces Commencement of Clinical Trial
SCOTTSDALE, AZ / ACCESSWIRE / August 2, 2023 / Unify Medical, Inc., a privately-held, smart surgical visualization technology company, announced...
Wearable Health Solutions, Inc. Settles $633,000 Legacy Debt at Significant Discount, Bolsters Financial Position for Future Growth
NEWPORT BEACH, CA / ACCESSWIRE / August 2, 2023 / Wearable Health Solutions, Inc. (OTC PINK:WHSI) ("WSHI or the "Company"),...
REMINDER: Napo Pharmaceuticals, a Jaguar Health Company, Supports Gay Men’s Health with Participation in Pineapple Healthcare’s “Butt Stuff Brunch with Dr. Carlton” August 5th
Napo Medical Affairs Team Member, who is an HIV/Mytesi® (Crofelemer) Patient, to Participate in Educational PanelSAN FRANCISCO, CA / ACCESSWIRE...
Oasis Employee Appreciation Month for August 2023
LAS VEGAS, NV / ACCESSWIRE / August 2, 2023 / Oasis Cannabis Dispensary has been recognized as the "locals'" dispensary...
NEXGEL to Report Second Quarter 2023 Financial Results on August 14th
Management will host a conference call at 4:30 P.M. ET on the same day LANGHORNE, Pa., Aug. 02, 2023 (GLOBE...
Alpha Tau Medical to Present at the Emerging Growth Conference on August 9th, 2023
JERUSALEM, Aug. 02, 2023 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the...
BLUEMOTH Introduces First-of-its-Kind Digital Prescription Hearing Technology Experience
The company offers a new destination for consumers to discover, try-on and purchase personalized hearing technology with audiologist supportSEATTLE, Aug....
Syneos Health Stockholders Approve Agreement with Private Investment Consortium
MORRISVILLE, N.C., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (“Syneos Health” or the “Company”), a leading...
Yield10 Bioscience Announces Positive Results in the First Field Test of Stacked Herbicide Tolerance Traits in Camelina, Supporting Large Acreage Production of Low-carbon Intensity Feedstock Oil for the Biofuel Market
-Findings demonstrate a key advancement in the development of proprietary Camelina varieties tolerant to application of broadleaf weed control as...
Petalfast Joins Forces with MATU to Bring Premium All-In-One Surf Vapes to the Massachusetts Cannabis Market
IRVINE, Calif., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Petalfast, a route-through-market platform for the cannabis industry, announced its partnership with...
Physician Partner of Castle Connolly Private Health Partners, Gary D. Schwartz, MD, Appointed to Valley Hospital
Gary D. Schwartz, MD Schwartz CCPHPPARAMUS, N.J., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Gary D. Schwartz, M.D., a board-certified internist...
Adamis Pharmaceuticals Announces Pricing of $8.0 Million Public Offering
SAN DIEGO, Aug. 02, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today announced the pricing...
RVL Pharmaceuticals plc to Discuss Second Quarter 2023 Financial Results and Provide Commercial Update
-- Conference call to be held Monday, August 14, 2023, at 8:30 a.m. ET --BRIDGEWATER, N.J., Aug. 02, 2023 (GLOBE...
Aridis Pharmaceuticals Announces $2 Million Offering
Los Gatos, Calif., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc. (OTC: ARDS), a biopharmaceutical company focused on the...
X4 Pharmaceuticals to Report Second-Quarter 2023 Financial Results and Host a Conference Call and Webcast on August 10, 2023
BOSTON, Aug. 02, 2023 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of novel...
Candel Therapeutics to Participate in the Canaccord Genuity 43rd Annual Growth Conference
NEEDHAM, Mass., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage...
First Patient Enrolled in LEOPARD, an Investigator-Initiated Trial, with OCS-01 Eye Drops for the Treatment of Cystoid Macular Edema
LEOPARD trial initiation follows recent positive data from OCS-01 eye drops from the Stage 1 Phase 3 DIAMOND trial in...